Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q4)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 42.44%-541.13K | -35.48%-329.69K | -144.69%-1.46M | 69.76%-135.6K | -8,959.09%-139.44K | -615.45%-940.11K | -1,266.74%-243.35K | 73.97%-596.07K | -265.72%-448.44K | 100.30%1.57K |
| Net income from continuing operations | -194.41%-967.37K | 14.91%-410.92K | 11.71%-2.38M | -50.97%-813.53K | -33.35%-750.45K | 61.93%-328.58K | 33.46%-482.93K | 17.81%-2.69M | 19.50%-538.86K | 26.10%-562.75K |
| Depreciation and amortization | -13.55%21.53K | -14.77%21.53K | -58.30%95.83K | -44.20%20.77K | -63.28%24.9K | -59.98%24.9K | -59.61%25.26K | -8.09%229.81K | -40.48%37.22K | 8.50%67.82K |
| Unrealized gains and losses of investment securities | ---747 | 154.23%385 | -103.42%-695 | -94.24%52 | -101.76%-37 | --0 | -109.12%-710 | -86.24%20.34K | 107.75%902 | -34.47%2.11K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.93%-238 | ---1.24K | ---- |
| Change In working capital | 163.71%405.46K | -72.41%59.32K | -55.45%821.85K | 1,150.71%657.11K | 18.56%586.14K | -196.43%-636.43K | -66.28%215.03K | 102.78%1.84M | -89.40%52.54K | 178.65%494.4K |
| -Change in receivables | -638.05%-23.48K | 112.91%6.4K | -258.77%-40.75K | -49.57%61.75K | -16.34%-57.26K | 135.46%4.36K | -40.72%-49.6K | -26.69%25.67K | 4,494.26%122.44K | -381.85%-49.22K |
| -Change in prepaid assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -91.77%22.7K | ---- | ---- |
| -Change in payables and accrued expense | 148.78%342.67K | -58.65%69K | -61.48%583.87K | 1,387.37%551.88K | 54.22%567.56K | -223.75%-702.43K | -69.28%166.86K | 154.32%1.52M | -89.97%37.1K | 247.70%368.02K |
| -Change in other working capital | 39.96%86.27K | -116.45%-16.09K | -0.59%278.73K | 133.52%43.48K | -56.81%75.84K | -41.14%61.64K | -24.65%97.77K | 10,162.55%280.37K | -1,074.54%-129.7K | 1,245.18%175.6K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 42.44%-541.13K | -35.48%-329.69K | -144.69%-1.46M | 69.83%-135.6K | -5,517.37%-139.44K | -615.45%-940.11K | -1,266.74%-243.35K | 73.97%-596.07K | -266.54%-449.44K | 100.50%2.57K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -109.40%-9.37K | ||||||||
| Net PPE purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---9.37K | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -109.40%-9.37K | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -42.29%542.28K | 35.93%329.9K | 140.30%1.46M | -70.70%134.79K | 5,142.15%140.07K | 614.78%939.69K | 1,270.50%242.7K | -53.25%606.42K | 289.89%460.02K | -100.64%-2.78K |
| Net issuance payments of debt | -54.76%347.98K | 177.43%256.9K | 99.22%1.12M | -70.70%134.79K | 4,702.95%127.87K | 485.06%769.16K | 481.22%92.6K | 1,404.87%564.42K | 3,584.61%460.02K | 84.86%-2.78K |
| Net common stock issuance | ---- | ---- | --272.53K | 118.81%7.9K | --264.63K | --115.53K | 257.38%150.1K | --0 | -939.66%-42K | --0 |
| Proceeds from stock option exercised by employees | --15K | -72.73%15K | --68.2K | --0 | --13.2K | --0 | --55K | --0 | --0 | --0 |
| Net other financing activities | -141.43%-70.57K | -39.01%58K | -118.81%-7.9K | ---- | ---- | --170.35K | --95.1K | -58.21%42K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -42.28%542.28K | 35.93%329.9K | 140.30%1.46M | -70.70%134.79K | 5,148.63%140.25K | 614.64%939.51K | 1,270.50%242.7K | -53.25%606.42K | 289.89%460.02K | -100.64%-2.78K |
| Net cash flow | ||||||||||
| Beginning cash position | -47.91%423 | -85.81%207 | 203.96%1.46K | 316.67%1.03K | -51.78%217 | 111.46%812 | 203.96%1.46K | -99.95%480 | -95.18%246 | -99.50%450 |
| Current changes in cash | 293.95%1.15K | 133.38%216 | -227.89%-1.25K | -167.44%-818 | 496.08%808 | -1,001.52%-595 | -573.96%-647 | 100.11%979 | 126.20%1.21K | 99.76%-204 |
| End cash Position | 626.73%1.58K | -47.91%423 | -85.81%207 | -85.81%207 | 316.67%1.03K | -51.78%217 | 111.46%812 | 203.96%1.46K | 203.96%1.46K | -95.18%246 |
| Free cash from | 42.44%-541.13K | -35.48%-329.69K | -140.90%-1.46M | 70.44%-135.6K | -5,517.37%-139.44K | -615.45%-940.11K | -1,266.74%-243.35K | 73.56%-605.44K | -274.19%-458.81K | 100.50%2.57K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.